Spire Wealth Management’s Acceleron Pharma XLRN Stock Holding History

Spire Wealth Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-440	Closed	-$76K	–	3039
2021 Q3	$76K	Sell	440 -303	-41%	-$39.6K	﹤0.01%	1306
2021 Q2	$93K	Sell	743 -14	-2%	-$1.77K	﹤0.01%	1205
2021 Q1	$103K	Buy	+757	New	+$97.8K	﹤0.01%	1393

Spire Wealth Management's XLRN Position: Q4 2021 in Review

Spire Wealth Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 440 shares — an estimated $76K sold.

Spire Wealth Management first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $103K in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Spire Wealth Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Spire Wealth Management sold 440 Acceleron Pharma shares in Q4 2021, an estimated $76K.
Spire Wealth Management first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
Spire Wealth Management's Acceleron Pharma position peaked at $103K in Q1 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Spire Wealth Management's 13F filing for Q4 2021, filed 14 Jan 2022.